SIMULECT subst sèche 20 mg c solv amp
7680546300180
CH-54630
L04AC02
07.15.0.
1 / 3
google
Details
- Product number
- 5463001
- CPT
- -
- Packaging group
- 1 + 1
- Unit
- Ampulle(n)
- Composition
- Praeparatio cryodesiccata: basiliximabum 20 mg, dinatrii phosphas, natrii chloridum, kalii dihydrogenophosphas, saccharum, glycinum, mannitolum, pro vitro corresp. natrium 0.955 mg. Solvens: aqua ad iniectabile pro vitro.
Articles (1)
Simulect 20 mg, Pulver und Lösungsmittel zur Herstellung einer Injektions-/Infusionslösung
Pulver und Lösungsmittel zur Herstellung einer Injektions-/Infusionslösung
1 + 1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
aqua ad iniectabile
|
- | Substance | HNIDK |
|
basiliximabum
|
20.0 MG | Substance | Wirkstoff (Principe actif) |
|
dinatrii phosphas
|
- | Substance | HNIDK |
|
natrii chloridum
|
- | Substance | HNIDK |
|
kalii dihydrogenophosphas
|
- | Substance | HNIDK |
|
saccharum
|
- | Substance | HNIDK |
|
glycinum
|
- | Substance | HNIDK |
|
mannitolum
|
- | Substance | HNIDK |
|
natrium
|
0.955 MG | Substance | HBESI |
Authorization holder
Novartis Pharma Schweiz AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 54630
- Drug name
- Simulect, Pulver und Lösungsmittel zur Herstellung einer Injektions-/Infusionslösung
- Galenic form
- PULMK
- ATC Code
- L04AC02
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 07/04/1998
- Authorization expiration date
- 31/12/9999
- IT number
- 07.15.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- SIMULECT subst sèche 20 mg c solv amp
- Description (DE)
- SIMULECT Trockensub 20 mg c Solv Amp
- Market launch
- 07/04/1998
- Narcotic (BTM)
- No